Conference Program Home
  My Program

All Times EDT

CC = Walter E. Washington Convention Center   M = Marriott Marquis Washington, DC
* = applied session       ! = JSM meeting theme

Activity Details

331 Tue, 8/9/2022, 2:00 PM - 3:50 PM CC-202A
ASA Biopharmaceutical Section Student Paper Award Competition — Contributed Papers
Biopharmaceutical Section
Chair(s): Mingzhao Hu, University of California, Santa Barbara
2:05 PM A New Clustering Method for Longitudinal Data
Junyi Zhou, Amgen; Ying Zhang, University of Nebraska Medical Center; Wanzhu Tu, INDIANA UNIVERSITY
2:20 PM A Synthetic Data Integration Framework to Leverage External Summary-Level Information from Heterogeneous Populations
Tian Gu, Harvard Chan School of Public Health; Jeremy Taylor, University of Michigan; Bhramar Mukherjee, University of Michigan
2:35 PM Learning Optimal Group-Structured Individualized Treatment Rules with Many Treatments
Haixu Ma, University of North Carolina at Chapel Hill; Donglin Zeng, University of North Carolina; Yufeng Liu, University of North Carolina
2:50 PM Semi-Supervised Mixture Multi-Source Exchangeability Model Approach for Incorporating Real World Data into Randomized Controlled Trial Analyses
Lillian Moran Fitzmorris Haine, University of Minnesota; Thomas Murray , University of Minnesota ; Raquel Nahra, Cooper Medical School of Rowan University and Cooper University Health Care; Giota Touloumi, Department of Hygiene, Epidemiology Medical Statistics, Medical School, National; Eduardo Fernández-Cruz, Hospital General Universitario Gregorio Marañón, Servicio de Immunología Clínica, Madrid; Kathy Petoumenos, The Kirby Institute, University of New South Wales, Sydney, Australia; Joseph Koopmeiners, University of Minnesota - Minneapolis, MN
3:05 PM BOB: Bayesian Optimal Design for Biosimilar Trials with Co-Primary Endpoints
Xiaohan Chi, Shanghai Jiao Tong University; Zhangsheng Yu, Shanghai Jiao Tong University; Ruitao Lin, MD Anderson
3:20 PM Longitudinal Monitoring of Antibiotics with Antimicrobial Susceptibility Testing
Will Eagan, Vertex Pharmaceuticals; Bruce A. Craig, Purdue University
3:35 PM Floor Discussion